3billion, Inc. at ASHG 2026

Oct 20–24, 2026 Montréal, Canada ~7.5k attendees Website

3billion, Inc. at ASHG 2026 in Montréal: 4 presentations (4 posters).

Organization	ASHG 2026 Attendance
3billion, Inc. Seoul, South Korea	1 Chief Technology Officer · 1 Clinical Genomics Scientist · 1 Lead Clinical Genomics Scientist · 1 other presenter
3billion.io\|LinkedIn Public company 3billion provides AI-powered genomic interpretation and rare disease diagnostic services to healthcare professionals in more than 75 countries and over 800 partner institutions worldwide. 3billion's GEBRA variant-interpretation software is now used or evaluated in more than 30 countries, showing rapid global adoption on AWS. › 3billion's GEBRA variant-interpretation software is now used or evaluated in more than 30 countries, showing rapid global adoption on AWS. 2026-09 · source 3billion presented its Family Insight test, a family-based precision genomic testing service, at a prenatal genetic counseling symposium. 2026-09 · source 3billion launched 3B-NEO, a genomic newborn screening service covering 595 clinically actionable genetic conditions, a new market entry. 2026-06 · source Source: company newsroom Q2 2026 revenue KRW 3.8B, up 46% › Growth accelerated 13% quarter over quarter; new initiatives expected to add revenue in H2 2026. · 2026-08-13 “Second-quarter revenue reached KRW 3.8 billion, up 46% year over year and 13% quarter over quarter.” Source: results release	Poster Wed Oct 21 2:30 pm Part of Laboratory Genetics and Genomics Poster Wednesday Session FindME: Bringing Mobile Element Insertion Detection into Routine Clinical WES/WGS Analysis for Rare Disease Diagnosis Exhibit & Poster Hall · Board 2034W BioinformaticsCopy number/structural variationVariant calling Poster Wed Oct 21 2:30 pm Part of Late-Breaking Poster Wednesday Session Overcoming the clinical bottleneck of depth-based CNV calling: An embedded GC correction model reduces review burden by 76% across 105,973 samples Exhibit & Poster Hall · Board 4011W BioinformaticsCopy number/structural variationGenomicsMathematical modeling Poster Thu Oct 22 4:15 pm Part of Health Services Research and Implementation Science Poster Thursday Session Scaling Precision Medicine: A Hybrid Implementation-Effectiveness Study of a National Genome Sequencing Program for Korean Rare Disease Families Exhibit & Poster Hall · Board 8034T Collaborators: Pusan National University Yangsan Hospital Clinical geneticsPublic healthRare variantsDiagnostics Poster Fri Oct 23 2:30 pm Part of Laboratory Genetics and Genomics Poster Friday Session PacBio HiFi long-read genome sequencing resolves short-read–challenging findings in rare disease diagnosis Exhibit & Poster Hall · Board 2050F Collaborators: Yonsei University, University of Ulsan +1 more Long-read sequencingLaboratory genetics and genomicsDiagnosticsExome/genome sequencing

Organization

ASHG 2026 Attendance

3billion, Inc.

Seoul, South Korea

1 Chief Technology Officer · 1 Clinical Genomics Scientist · 1 Lead Clinical Genomics Scientist · 1 other presenter

3billion.io|LinkedIn

Public company

3billion provides AI-powered genomic interpretation and rare disease diagnostic services to healthcare professionals in more than 75 countries and over 800 partner institutions worldwide.

3billion's GEBRA variant-interpretation software is now used or evaluated in more than 30 countries, showing rapid global adoption on AWS.

›

3billion's GEBRA variant-interpretation software is now used or evaluated in more than 30 countries, showing rapid global adoption on AWS.

2026-09 · source

3billion presented its Family Insight test, a family-based precision genomic testing service, at a prenatal genetic counseling symposium.

2026-09 · source

3billion launched 3B-NEO, a genomic newborn screening service covering 595 clinically actionable genetic conditions, a new market entry.

2026-06 · source

Source: company newsroom

Q2 2026 revenue KRW 3.8B, up 46%

›

Growth accelerated 13% quarter over quarter; new initiatives expected to add revenue in H2 2026. · 2026-08-13

“Second-quarter revenue reached KRW 3.8 billion, up 46% year over year and 13% quarter over quarter.”

Source: results release

Poster

Wed Oct 21
2:30 pm

Part of Laboratory Genetics and Genomics Poster Wednesday Session

FindME: Bringing Mobile Element Insertion Detection into Routine Clinical WES/WGS Analysis for Rare Disease Diagnosis

Exhibit & Poster Hall · Board 2034W

BioinformaticsCopy number/structural variationVariant calling

Poster

Wed Oct 21
2:30 pm

Part of Late-Breaking Poster Wednesday Session

Overcoming the clinical bottleneck of depth-based CNV calling: An embedded GC correction model reduces review burden by 76% across 105,973 samples

Exhibit & Poster Hall · Board 4011W

BioinformaticsCopy number/structural variationGenomicsMathematical modeling

Poster

Thu Oct 22
4:15 pm

Part of Health Services Research and Implementation Science Poster Thursday Session

Scaling Precision Medicine: A Hybrid Implementation-Effectiveness Study of a National Genome Sequencing Program for Korean Rare Disease Families

Exhibit & Poster Hall · Board 8034T

Collaborators: Pusan National University Yangsan Hospital

Clinical geneticsPublic healthRare variantsDiagnostics

Poster

Fri Oct 23
2:30 pm

Part of Laboratory Genetics and Genomics Poster Friday Session

PacBio HiFi long-read genome sequencing resolves short-read–challenging findings in rare disease diagnosis

Exhibit & Poster Hall · Board 2050F

Collaborators: Yonsei University, University of Ulsan +1 more

Long-read sequencingLaboratory genetics and genomicsDiagnosticsExome/genome sequencing

Instantly find 20 buyers from 3billion, Inc.

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the American Society of Human Genetics. Submit a correction